You are currently viewing a new version of our website. To view the old version click .
Pharmaceuticals
  • Correction
  • Open Access

13 June 2019

Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13

,
,
,
,
and
Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine
In our paper [], an error unfortunately occurred in Figure 1. We therefore would like to provide the readers with the corrected figure and apologize for this inconvenience.
Figure 1. Amino acid sequence and chemical structure of (a) HYNIC-MGS5 and (b) HYNIC-MGS11.

Reference

  1. Klingler, M.; Rangger, C.; Summer, D.; Kaeopookum, P.; Decristoforo, C.; von Guggenberg, E. Cholecystokinin-2 Receptor targeting with novel C-terminally stabilized HYNIC-Minigastrin Analogs radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13. [Google Scholar] [CrossRef] [PubMed]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.